Ligand profile
CHEMBL28079
Bioactivity hit from ChEMBL on a similar protein.
Bound to: VK055_4925 — apurinic endonuclease family protein
Identifiers
Database identifiers and provenance.
- Ligand ID
CHEMBL28079- UniProt (similar protein)
P0A6C1- pchembl
- 6.700 (~199.5 nM)
- Target protein
- VK055_4925
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 96.5
- −1 ≤ LogP ≤ 5 1.50
- MW ≤ 500 Da 271.3
- LogP ≤ 5 1.50
- H-bond donors ≤ 5 2
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 4
- TPSA ≤ 140 Ų 96.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1CCCOc1ccccc1-c1nc2[nH]nnc2c(=O)[nH]1
InChI=1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)InChI=1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)
REZGGXNDEMKIQB-UHFFFAOYSA-NREZGGXNDEMKIQB-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Source
- ChEMBL
- Activity
- Inconclusive
- Binding sites
- PF01261
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ChEMBL ChEMBL compound CHEMBL28079 →
- UniProt UniProt P0A6C1 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “CHEMBL28079”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_4925.
ChEMBL 63
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 50
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).